Publications by authors named "Kengo Nanya"
Front Immunol
October 2022
Article Synopsis
- The study evaluated the immune response to the BNT162b2 SARS-CoV-2 vaccine in patients with neuromuscular disorders (NMDs) like spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) compared to healthy subjects.
- Antibody levels after vaccination were similar between NMD patients and healthy individuals, indicating that patients with these disorders have a comparable immune response to the vaccine.
- The findings suggest that the BNT162b2 vaccine is both safe and effective for individuals with NMDs, with no significant differences in adverse reactions compared to healthy participants.
